Navigation Links
NeurogesX Reports Third Quarter 2009 Results
Date:11/6/2009

ng on November 16, 2009 by dialing 1-877-660-6853 (USA) or 1-201-612-7415 (International), Account Number: 3055, Conference ID Number: 336156. A replay of the webcast will also be available on the corporate website for one month, through December 6, 2009.

About NeurogesX, Inc.

NeurogesX (Nasdaq: NGSX) is a biopharmaceutical company focused on developing and commercializing novel pain management therapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), painful HIV-distal sensory polyneuropathy (HIV-DSP) and painful diabetic neuropathy (PDN). NeurogesX' late stage product portfolio is led by its product candidate Qutenza(TM), a dermal patch designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the treatment of neuropathic pain in non-diabetic adults, either alone or in combination with other medicinal products for pain. Qutenza will be marketed in the European Union, Switzerland, Norway, Iceland, Liechtenstein and certain countries in Eastern Europe, the Middle East and Africa, by Astellas Pharma Europe, Ltd. In the United States, NeurogesX submitted a new drug application (NDA) for PHN to the U.S. Food and Drug Administration (FDA) which was accepted for filing by the FDA in December 2008 and has been given an extended Prescription Drug User Fee Act (PDUFA) date of November 16, 2009.

NeurogesX' second most advanced product candidate, NGX-1998, is a topically applied, liquid formulation containing a high concentration of capsaicin designed to treat pain associated with neuropathic pain conditions. NGX-1998 has completed three Phase 1 studies and NeurogesX is currently planning the design and timing of this program.

NeurogesX' early stage product pipeline includes pre-clinic
'/>"/>

SOURCE NeurogesX
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. NeurogesX to Present at Two November Conferences
2. NeurogesX to Present at UBS Global Life Sciences Conference
3. NeurogesX to Present at Upcoming Fall Conferences
4. NeurogesX Appoints New Board Director and Audit Committee Chairman
5. NeurogesX Reports Second Quarter 2009 Results
6. NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
7. NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
8. NeurogesX Added to Russell 3000 Index
9. NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
10. NeurogesX to Present at Needham Life Sciences Conference
11. NeurogesX Receives European Commission Approval for Qutenza(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2010)... mechanisms critical to interactions between hot plasma and ... reactor, part of work aimed at developing coatings ... reactors. , Fusion powers the stars and could ... A fusion power plant would produce 10 times ... and because the deuterium fuel is contained in ...
(Date:7/27/2010)... point to accelerated growth in China ,s domestic market:  rising ... services, central government policy continues to urge greater consumption of goods. ... Wednesday, September 8 , executives and managers can learn how to ... , , , ... companies now figuring out how to approach the high growth market, ...
(Date:7/27/2010)... , July 27 Adeona Pharmaceuticals, Inc., ... Caudill , B.B.A., has been appointed Vice President of Finance ... 15 years of biotechnology-related accounting and Securities and Exchange Commission ... , ... in a variety of financial reporting positions at Aastrom Biosciences, ...
(Date:7/26/2010)... /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) will conduct ... on Thursday, August 5, 2010 at 4:30 p.m. ... , , ... call by telephone, please dial (877) 280-7291 ( United States ) ... live and can be accessed on the "Events" page of the ...
Breaking Biology Technology:Findings show promise for nuclear fusion test reactors 2Findings show promise for nuclear fusion test reactors 3Orchestrall Sponsors 'China Business Toolbox': Brings Focus to the 'How and When' of China Market Access 2Orchestrall Sponsors 'China Business Toolbox': Brings Focus to the 'How and When' of China Market Access 3Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller 2Adeona Appoints Julie A. Caudill, B.B.A., Vice President of Finance and Corporate Controller 3
... Quarter Target Agreed, GENEVA, Switzerland, February 11 ... have agreed with Molecular Vision and The Imperial ... of Molecular Vision. Following the,initial acquisition of 10.9% ... month, it has now been agreed by all ...
... on Status of Integration Planning -, SOUTH ... Sheets: VXGN), a biopharmaceutical company, and Raven,biotechnologies, inc. ... monoclonal antibody therapeutics (MAbs) for treating cancer, announced,today ... to the,proposed merger with Raven biotechnologies has been ...
... Calif., Feb. 11 Cepheid (Nasdaq:,CPHD) today announced ... as,Senior Vice President, Chief Financial Officer on April ... operations and investor,relations. Mr. Miller will report to ... Sluis, who retired from Cepheid effective,December 31, 2007., ...
Other Biology Technology:Acrongenomics on Track to Acquire Molecular Vision 2Acrongenomics on Track to Acquire Molecular Vision 3Acrongenomics on Track to Acquire Molecular Vision 4VaxGen and Raven Announce Form S4 Registration Statement Declared Effective 2VaxGen and Raven Announce Form S4 Registration Statement Declared Effective 3VaxGen and Raven Announce Form S4 Registration Statement Declared Effective 4VaxGen and Raven Announce Form S4 Registration Statement Declared Effective 5Cepheid Appoints Senior VP, Chief Financial Officer to Management Team 2
(Date:7/29/2010)... 29, 2010) Polymer strands wriggle their way through ... to there and do their jobs. New theoretical research ... journey takes. , That,s a good thing to ... and proteins -- all of which count as polymers ... in biosensors or as drug-delivery devices. , ...
(Date:7/29/2010)... black carbon to sulfate in the atmosphere increases climate ... Iowa professor and his colleagues and published in the ... . , Black carbons -- arising from such sources ... widely considered a factor in global warming and are ... according to Greg Carmichael, Karl Kammermeyer Professor of Chemical ...
(Date:7/29/2010)... Washington, D.C (July 29, 2010) While pundits write ... climate changes are already being felt across the world. ... ways that managers have never before seen. , ... these changes. In that effort, Island Press and EcoAdapt ... Climate Adaptation Knowledge Exchange (CAKE) at www.cakex.org . ...
Breaking Biology News(10 mins):Polymer passage takes time 2Study finds black carbon implicated in global warming 2CAKE offers way forward for climate change adaptation 2Paralyzed Artist Launches WillWalk Foundation to Cure Paralysis with Breakthrough Stem Cell Research 4987 1Paralyzed Artist Launches WillWalk Foundation to Cure Paralysis with Breakthrough Stem Cell Research 4987 2Latino HIV AIDS Crisis Demands Attention Health Care Professionals from Across the United States Gather in New York City for National Conference on 57001 1Latino HIV AIDS Crisis Demands Attention Health Care Professionals from Across the United States Gather in New York City for National Conference on 57001 2Latino HIV AIDS Crisis Demands Attention Health Care Professionals from Across the United States Gather in New York City for National Conference on 57001 3LeBow 26amp 3B Associates Moves to New Office in Manhattan 56998 1LeBow 26amp 3B Associates Moves to New Office in Manhattan 56998 2
... A team including researchers at the HudsonAlpha Institute ... number of other organizations, today publishes a comprehensive ... glioblastoma. These results are the first from the ... effort funded by the National Cancer Institute and ...
... 4, 2008) A variety of organismsfrom bacteria ... the timing and duration of fundamental biological processes is ... even under fluctuating environmental conditions. In recent years, ... basis of these rhythms and how they translate into ...
... that obesity and Type 2 Diabetes Mellitus (T2DM) can contribute ... the first study to show that obesity can cause ... Disease Volume 15:1 (September 2008) . , In ... Monte, MD, MPH, of Rhode Island Hospital, utilized chronic high ...
Other Biology News:Collaboration between researchers yields more comprehensive portrait of brain cancer 2Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...
Rabbit anti MMP-13, Hinge Region MMP-13 Hinge Region...
Biology Products: